Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Neoplasms 15Endometrial Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Rectal Neoplasms 4Ovarian Neoplasms 4Head and Neck Neoplasms 4Pancreatic Neoplasms 3Melanoma 3Colonic Neoplasms 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Osteosarcoma 2Locally Advanced Rectal Cancer (LARC) 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Neuroendocrine 2Carcinoma, Hepatocellular 2Carcinoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1

Interventions

Temozolomide 6Radiotherapy 4Cyclophosphamide 3TIC10 compound 2Specimen Handling 2Irinotecan 2Granulocyte-Macrophage Colony-Stimulating Factor 2Everolimus 2Etoposide 2Diphtheria-Tetanus Vaccine 2tovorafenib 1spartalizumab 1ribociclib 1pembrolizumab 1lutetium Lu 177 dotatate 1lorlatinib 1larotrectinib 1gallium maltolate 1fimepinostat 1etoposide phosphate 1dostarlimab 1dipinacoline glutamate 1dinutuximab 1balstilimab 1antineoplaston AS 2-1 1antineoplaston A10 1abemaciclib 1Vaccines 1Topotecan 1Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diffuse Intrinsic Pontine Glioma × dostarlimab × 1 year × Clear all
NCT06521567 2025-11-12

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

GlaxoSmithKline

Phase 1/2 Active not recruiting
83 enrolled
CNSDermatologicGastrointestinalLymphoidSarcoma

Fibrolamellar hepatocellular carcinoma, Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Melanoma, Rhabdomyosarcoma, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡